Biotech ThinkCyte Secures $32 million in Series C Funding to Drive Global Expansion of VisionSort™ September 4, 2024
Biotech Revolutionizing Home Sustainability GEME Debuts the Future of Composting at IFA Berlin 2024 August 27, 2024
Biotech IDEAYA Biosciences to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference August 26, 2024
Biotech CONCEPT MEDICAL ANNOUNCES ENROLLMENT OF FIRST PATIENT IN “MAGICAL-ISR” IDE STUDY IN THE US August 20, 2024
Biotech Tony Kouzarides, Founder of STORM Therapeutics, Awarded British Knighthood for Services to Healthcare Innovation and Delivery August 20, 2024
Biotech Precigen to Announce Second Quarter and First Half 2024 Financial Results on August 14th August 16, 2024
Biotech The Galien Foundation Announces 2024 Prix Galien USA Nominees for “Best Biotechnology Product,” “Best Pharmaceutical Product” and “Best Product for Rare/Orphan Diseases” August 16, 2024
Biotech Foresee Pharmaceuticals Announces Several New Developments Related to its SIF Long-Acting Injectable (LAI) Technologies – Solidifying its Position as a Leader in Complex Long-Acting Injectable Products August 16, 2024
Biotech First patient enrollment in the U.S. – A milestone for the global multi-center phase Ⅲ clinical trial of telitacicept for myasthenia gravis August 12, 2024